Brad Hirsch's guest appearances

Brad Hirsch

Tech Tonics

The Health Technology Podcast

Machine Meets World

Paul Ford

Daphne Koller

Sean Gourley

Michelle Meyer

Brian Smith

Dan Faggella

Rob Delaney

Dan Schawbel

Scott Stephenson

John Deere

Stephanie Tilenius

Booz Allen Hamilton

Daniel Faggella

Doug Sauder

Dave Albert

OwlTail

What do you get when you mix a doctor’s caring heart and a businessman's entrepreneurial mind? Well, you would get Brad Hirsch, a medical oncologist who is now the Head of Product &amp; Implementation, at Verily, a healthcare technology solutions company. From serving as Senior Medical Director at Flatiron Health to serving on faculty at Duke University, Brad has really done it all. Brad has put together his clinical background and research knowledge into a new business ecosystem to help improve clinical trial execution. Brad walks us through about his journey to founding Signal Health and his reflections on this exciting venture from oncologist to entrepreneurship in the HealthTech space. Do you have any thoughts? Please email us at hello@rosenmaninstitute.org. We post new episodes every Monday. “The Health Technology Podcast” is produced by Herminio Neto, hosted by Christine Winoto, and engineered by Andrew John Rojek

What do you get when you mix a doctor’s caring heart and a businessman's entrepreneurial mind? Well, you would get <a href="https://www.linkedin.com/in/brad-hirsch/" rel="nofollow" target="_blank">Brad Hirsch</a>, a medical oncologist who is now the Head of Product &amp; Implementation, at Verily, a healthcare technology solutions company. From serving as Senior Medical Director at Flatiron Health to serving on faculty at Duke University, Brad has really done it all. Brad has put together his clinical background and research knowledge into a new business ecosystem to help improve clinical trial execution. Brad walks us through about his journey to founding Signal Health and his reflections on this exciting venture from oncologist to entrepreneurship in the HealthTech space. Do you have any thoughts? Please email us at <a href="mailto:hello@rosenmaninstitute.org">hello@rosenmaninstitute.org</a>. We post new episodes every Monday. “<a href="https://rosenmaninstitute.org/podcast/" rel="nofollow" target="_blank">The Health Technology Podcast</a>” is produced by <a href="https://www.linkedin.com/in/herminioneto/" rel="nofollow" target="_blank">Herminio Neto</a>, hosted by <a href="https://www.linkedin.com/in/christine-winoto-8b412b/" rel="nofollow" target="_blank">Christine Winoto</a>, and engineered by <a href="https://www.linkedin.com/in/aj-rojek/" rel="nofollow" target="_blank">Andrew John Rojek</a>

Brad Hirsch: Revolutionizing Clinical Trials

Brad Hirsch , CEO and co-founder of SignalPath, talks artificial intelligence and medical trials with James Kotecki of Infinia ML. --- EPISODE HIGHLIGHTS Why SignalPath automation doesn’t put jobs at risk [7:08 and 9:37] The next frontier for automation in clinical trials [14:43] The promise of less busywork and more helpful science [17:13] Optimism for the future of clinical trials [25:34] --- EMAIL THE SHOW mmw@infiniaml.com --- Video and transcript: https://medium.com/machine-meets-world/less-busywork-more-science-457d9be6aedc?source=collection_home---4------6-----------------------

Brad Hirsch , CEO and co-founder of SignalPath, talks artificial intelligence and medical trials with James Kotecki of Infinia ML. --- EPISODE HIGHLIGHTS Why SignalPath automation doesn’t put jobs at risk [7:08 and 9:37] The next frontier for automation in clinical trials [14:43] The promise of less busywork and more helpful science [17:13] Optimism for the future of clinical trials [25:34] --- EMAIL THE SHOW <a href="mailto:mmw@infiniaml.com.">mmw@infiniaml.com</a> --- Video and transcript: <a href="https://medium.com/machine-meets-world/less-busywork-more-science-457d9be6aedc?source=collection_home---4------6-----------------------" rel="nofollow" target="_blank">https://medium.com/machine-meets-world/less-busywork-more-science-457d9be6aedc?source=collection_home---4------6-----------------------</a>

SignalPath CEO Brad Hirsch on Doing Less Busywork and More Science

If Alex P. Keaton was from Texas, went on to med school, and then trained in oncology, he might have emerged looking something like today’s guest, Dr. Brad Hirsch, an MD/MBA with a doctor’s heart and a businessman’s head, who’s now busy integrating both of these qualities as CEO of SignalPath, a company trying to improve the execution of clinical trials. Brad grew up in Texas, the son of a corporate CEO (who’s now a private equity executive). From an early age, Brad was interested in medicine, as well as business, and studied both biology and economics at the University of Pennsylvania, and went on to pursue both medicine – internal medicine then oncology – and business; he was especially interested in the intersection of the two, and thought there must be ways to improve the way care is delivered. (Tech Tonic listeners may recall very similar sentiments from previous guest Bob Kocher, see here). Following somewhat contrasting experiences at McKessen and Flatiron, Brad became CEO of SignalPath, a company that spun out of Duke and which is focused on pragmatically using technology and data to improve the operations of clinical trial sites, with a particular focus on simplifying the life of the clinical site coordinator. On today’s show, we also learn about Brad’s formative outdoor leadership experiences in Alaska and Utah, and his equally memorable experiences as a med student at University of Texas-Southwestern’s famously demanding Parkland Hospital. Brad also helps us understand why this health tech entrepreneur was so determined to return to the Lone Star State. Today’s episode is sponsored by Rockpointe: innovators in medical education and patient engagement.  To learn more go to: RockpointE.com

If Alex P. Keaton was from Texas, went on to med school, and then trained in oncology, he might have emerged looking something like today’s guest, <a href="https://www.linkedin.com/in/brad-hirsch-3646b22a/" rel="nofollow" target="_blank">Dr. Brad Hirsch</a>, an MD/MBA with a doctor’s heart and a businessman’s head, who’s now busy integrating both of these qualities as CEO of <a href="http://signalpath.com/" rel="nofollow" target="_blank">SignalPath</a>, a company trying to improve the execution of clinical trials. Brad grew up in Texas, the son of a corporate CEO (who’s now a private equity executive). From an early age, Brad was interested in medicine, as well as business, and studied both biology and economics at the University of Pennsylvania, and went on to pursue both medicine – internal medicine then oncology – and business; he was especially interested in the intersection of the two, and thought there must be ways to improve the way care is delivered. (Tech Tonic listeners may recall very similar sentiments from previous guest <a href="https://venturevalkyrie.com/tech-tonics-podcast-bob-kocher-on-fixing-hospitals-and-healthcare/" rel="nofollow" target="_blank">Bob Kocher</a>, see here). Following somewhat contrasting experiences at McKessen and Flatiron, Brad became CEO of SignalPath, a company that spun out of Duke and which is focused on pragmatically using technology and data to improve the operations of clinical trial sites, with a particular focus on simplifying the life of the clinical site coordinator. On today’s show, we also learn about Brad’s formative outdoor leadership experiences in Alaska and Utah, and his equally memorable experiences as a med student at University of Texas-Southwestern’s famously demanding Parkland Hospital. Brad also helps us understand why this health tech entrepreneur was so determined to return to the Lone Star State. Today’s episode is sponsored by <a href="http://rockpointe.com" rel="nofollow" target="_blank">Rockpointe</a>: innovators in medical education and patient engagement. <a href="http://www.rockpointe.com/" rel="nofollow" target="_blank"></a> To learn more go to: <a href="http://www.rockpointe.com/" rel="nofollow" target="_blank">RockpointE.com</a>

Tech Tonics: Brad Hirsch, A Cancer Doctor With Management Chops